Oxford Nanopore Technologies Investor Relations Material
Latest events
H2 2023
Oxford Nanopore Technologies
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Oxford Nanopore Technologies plc
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe & U.K.
Americas
China
United Arab Emirates
Other
Expenses by
Financials
Oxford Nanopore Technologies Limited provides nanopore-based data analysis systems for biomedical and industrial applications. The company offers PromethION, a benchtop nano-sensor for human DNA and RNA sequencing; MinION, a portable device for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing; GridION, a self-contained bench top device for running and processing up to five MinION or Flongle flow cells; PromethION 24 and PromethION 48, sequencing systems for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an alternative laboratory equipment.
Key slides for Oxford Nanopore Technologies plc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Oxford Nanopore Technologies plc
H2 2023
Oxford Nanopore Technologies plc
Latest articles
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Ticker symbol
Country
🇬🇧 United Kingdom